Skip to main content
Erschienen in: Pediatric Cardiology 6/2021

04.05.2021 | Original Article

Sizing Up Fontan Failure: Association with Increasing Weight in Adulthood

verfasst von: Ryan D. Byrne, Angela J. Weingarten, Daniel E. Clark, Steven J. Healan, Tadarro L. Richardson, Shi Huang, Jonathan N. Menachem, Benjamin P. Frischhertz

Erschienen in: Pediatric Cardiology | Ausgabe 6/2021

Einloggen, um Zugang zu erhalten

Abstract

Obesity has become increasingly recognized in adults with Fontan palliation, yet the relationship between weight changes in adulthood and Fontan failure is not clearly defined. We hypothesize that increasing weight in adulthood among Fontan patients is associated with the development of Fontan failure. Single-center data from adults with Fontan palliation who were not in Fontan failure at their first clinic visit in adulthood and who received ongoing care were retrospectively collected. Fontan failure was defined as death, transplant, diagnosis of protein losing enteropathy, predicted peak VO2 less than 50%, or new loop diuretic requirement. Anthropometric data including weight and BMI were collected. Change in weight was compared between those that developed Fontan failure, and those that remained failure-free. To estimate the association between weight change during adulthood and the risk of developing Fontan failure, a survival analysis using multiple Cox’s proportional hazards regression model was performed. Overall, 104 patients were included in the analysis. Those that developed Fontan failure had a larger associated median weight gain than those who remained failure-free (7.8 kg vs. 4.9 kg, respectively; p = 0.011). In multivariable Cox regression analysis, increased weight during adulthood was associated with increased likelihood of developing Fontan failure (HR 1.36; CI 1.07–1.73; p = 0.011). Weight gain in adulthood is associated with the development of Fontan failure.
Literatur
1.
Zurück zum Zitat Pundi KN, Johnson JN, Dearani JA, Li Z, Hinck CA, Dahl SH et al (2015) 40-Year follow-up after the fontan operation: long-term outcomes of 1,052 patients. J Am Coll Cardiol 66(15):1700–1710PubMedCrossRef Pundi KN, Johnson JN, Dearani JA, Li Z, Hinck CA, Dahl SH et al (2015) 40-Year follow-up after the fontan operation: long-term outcomes of 1,052 patients. J Am Coll Cardiol 66(15):1700–1710PubMedCrossRef
2.
Zurück zum Zitat Ogden CL, Carroll MD, Fryar CD, Flegal KM (2015) prevalence of obesity among adults and youth: United States, 2011–2014. NCHS Data Brief 219:1–8 Ogden CL, Carroll MD, Fryar CD, Flegal KM (2015) prevalence of obesity among adults and youth: United States, 2011–2014. NCHS Data Brief 219:1–8
3.
Zurück zum Zitat Pinto NM, Marino BS, Wernovsky G, de Ferranti SD, Walsh AZ, Laronde M et al (2007) Obesity is a common comorbidity in children with congenital and acquired heart disease. Pediatrics 120(5):e1157–e1164PubMedCrossRef Pinto NM, Marino BS, Wernovsky G, de Ferranti SD, Walsh AZ, Laronde M et al (2007) Obesity is a common comorbidity in children with congenital and acquired heart disease. Pediatrics 120(5):e1157–e1164PubMedCrossRef
4.
Zurück zum Zitat Zaqout M, Vandekerckhove K, Michels N, Demulier L, Bove T, François K et al (2019) Body mass index in adults with congenital heart disease. Congenit Heart Dis 14(3):479–486PubMedCrossRef Zaqout M, Vandekerckhove K, Michels N, Demulier L, Bove T, François K et al (2019) Body mass index in adults with congenital heart disease. Congenit Heart Dis 14(3):479–486PubMedCrossRef
5.
Zurück zum Zitat Cohen MI, Bush DM, Ferry RJ, Spray TL, Moshang T, Wernovsky G et al (2000) Somatic growth failure after the Fontan operation. Cardiol Young 10(5):447–457PubMedCrossRef Cohen MI, Bush DM, Ferry RJ, Spray TL, Moshang T, Wernovsky G et al (2000) Somatic growth failure after the Fontan operation. Cardiol Young 10(5):447–457PubMedCrossRef
6.
Zurück zum Zitat Freud LR, Webster G, Costello JM, Tsao S, Rychlik K, Backer CL et al (2015) Growth and obesity among older single ventricle patients presenting for Fontan conversion. World J Pediatr Congenit Heart Surg 6(4):514–520PubMedPubMedCentralCrossRef Freud LR, Webster G, Costello JM, Tsao S, Rychlik K, Backer CL et al (2015) Growth and obesity among older single ventricle patients presenting for Fontan conversion. World J Pediatr Congenit Heart Surg 6(4):514–520PubMedPubMedCentralCrossRef
7.
Zurück zum Zitat Wellnitz K, Harris IS, Sapru A, Fineman JR, Radman M (2015) Longitudinal development of obesity in the post-Fontan population. Eur J Clin Nutr 69(10):1105–1108PubMedCrossRef Wellnitz K, Harris IS, Sapru A, Fineman JR, Radman M (2015) Longitudinal development of obesity in the post-Fontan population. Eur J Clin Nutr 69(10):1105–1108PubMedCrossRef
8.
Zurück zum Zitat Chung ST, Hong B, Patterson L, Petit CJ, Ham JN (2016) High overweight and obesity in Fontan patients: a 20-year history. Pediatr Cardiol 37(1):192–200PubMedCrossRef Chung ST, Hong B, Patterson L, Petit CJ, Ham JN (2016) High overweight and obesity in Fontan patients: a 20-year history. Pediatr Cardiol 37(1):192–200PubMedCrossRef
9.
Zurück zum Zitat Cohen MS, Zak V, Atz AM, Printz BF, Pinto N, Lambert L et al (2010) Anthropometric measures after Fontan procedure: implications for suboptimal functional outcome. Am Heart J 160(6):1092–8, 98.e1 Cohen MS, Zak V, Atz AM, Printz BF, Pinto N, Lambert L et al (2010) Anthropometric measures after Fontan procedure: implications for suboptimal functional outcome. Am Heart J 160(6):1092–8, 98.e1
10.
Zurück zum Zitat Carbone S, Lavie CJ, Arena R (2017) Obesity and heart failure: focus on the obesity paradox. Mayo Clin Proc 92(2):266–279PubMedCrossRef Carbone S, Lavie CJ, Arena R (2017) Obesity and heart failure: focus on the obesity paradox. Mayo Clin Proc 92(2):266–279PubMedCrossRef
11.
Zurück zum Zitat Kenchaiah S, Evans JC, Levy D, Wilson PW, Benjamin EJ, Larson MG et al (2002) Obesity and the risk of heart failure. N Engl J Med 347(5):305–313PubMedCrossRef Kenchaiah S, Evans JC, Levy D, Wilson PW, Benjamin EJ, Larson MG et al (2002) Obesity and the risk of heart failure. N Engl J Med 347(5):305–313PubMedCrossRef
12.
Zurück zum Zitat Alpert MA, Lavie CJ, Agrawal H, Aggarwal KB, Kumar SA (2014) Obesity and heart failure: epidemiology, pathophysiology, clinical manifestations, and management. Transl Res 164(4):345–356PubMedCrossRef Alpert MA, Lavie CJ, Agrawal H, Aggarwal KB, Kumar SA (2014) Obesity and heart failure: epidemiology, pathophysiology, clinical manifestations, and management. Transl Res 164(4):345–356PubMedCrossRef
13.
Zurück zum Zitat Horwich TB, Fonarow GC, Hamilton MA, MacLellan WR, Woo MA, Tillisch JH (2001) The relationship between obesity and mortality in patients with heart failure. J Am Coll Cardiol 38(3):789–795PubMedCrossRef Horwich TB, Fonarow GC, Hamilton MA, MacLellan WR, Woo MA, Tillisch JH (2001) The relationship between obesity and mortality in patients with heart failure. J Am Coll Cardiol 38(3):789–795PubMedCrossRef
14.
Zurück zum Zitat Lavie CJ, Mehra MR, Milani RV (2005) Obesity and heart failure prognosis: paradox or reverse epidemiology? Eur Heart J 26(1):5–7PubMedCrossRef Lavie CJ, Mehra MR, Milani RV (2005) Obesity and heart failure prognosis: paradox or reverse epidemiology? Eur Heart J 26(1):5–7PubMedCrossRef
15.
Zurück zum Zitat Brida M, Dimopoulos K, Kempny A, Liodakis E, Alonso-Gonzalez R, Swan L et al (2017) Body mass index in adult congenital heart disease. Heart 103(16):1250–1257PubMedCrossRef Brida M, Dimopoulos K, Kempny A, Liodakis E, Alonso-Gonzalez R, Swan L et al (2017) Body mass index in adult congenital heart disease. Heart 103(16):1250–1257PubMedCrossRef
16.
Zurück zum Zitat Martinez SC, Byku M, Novak EL, Cedars AM, Eghtesady P, Ludbrook PA et al (2016) Increased body mass index is associated with congestive heart failure and mortality in adult fontan patients. Congenit Heart Dis 11(1):71–79PubMedCrossRef Martinez SC, Byku M, Novak EL, Cedars AM, Eghtesady P, Ludbrook PA et al (2016) Increased body mass index is associated with congestive heart failure and mortality in adult fontan patients. Congenit Heart Dis 11(1):71–79PubMedCrossRef
17.
Zurück zum Zitat d’Udekem Y, Iyengar AJ, Cochrane AD, Grigg LE, Ramsay JM, Wheaton GR et al (2007) The Fontan procedure: contemporary techniques have improved long-term outcomes. Circulation 116(11 Suppl):I157–I164PubMed d’Udekem Y, Iyengar AJ, Cochrane AD, Grigg LE, Ramsay JM, Wheaton GR et al (2007) The Fontan procedure: contemporary techniques have improved long-term outcomes. Circulation 116(11 Suppl):I157–I164PubMed
18.
Zurück zum Zitat Daley M, d’Udekem Y (2019) In patients undergoing Fontan completion, does a younger age at operation result in better long-term exercise capacity and prognosis? Interact Cardiovasc Thorac Surg 28(2):301–305PubMedCrossRef Daley M, d’Udekem Y (2019) In patients undergoing Fontan completion, does a younger age at operation result in better long-term exercise capacity and prognosis? Interact Cardiovasc Thorac Surg 28(2):301–305PubMedCrossRef
19.
Zurück zum Zitat Anderson PA, Sleeper LA, Mahony L, Colan SD, Atz AM, Breitbart RE et al (2008) Contemporary outcomes after the Fontan procedure: a Pediatric Heart Network multicenter study. J Am Coll Cardiol 52(2):85–98PubMedPubMedCentralCrossRef Anderson PA, Sleeper LA, Mahony L, Colan SD, Atz AM, Breitbart RE et al (2008) Contemporary outcomes after the Fontan procedure: a Pediatric Heart Network multicenter study. J Am Coll Cardiol 52(2):85–98PubMedPubMedCentralCrossRef
20.
Zurück zum Zitat Pemberton VL, McCrindle BW, Barkin S, Daniels SR, Barlow SE, Binns HJ et al (2010) Report of the National Heart, Lung, and Blood Institute’s Working Group on obesity and other cardiovascular risk factors in congenital heart disease. Circulation 121(9):1153–1159PubMedPubMedCentralCrossRef Pemberton VL, McCrindle BW, Barkin S, Daniels SR, Barlow SE, Binns HJ et al (2010) Report of the National Heart, Lung, and Blood Institute’s Working Group on obesity and other cardiovascular risk factors in congenital heart disease. Circulation 121(9):1153–1159PubMedPubMedCentralCrossRef
22.
Zurück zum Zitat Chen C, Ye Y, Zhang Y, Pan XF, Pan A (2019) Weight change across adulthood in relation to all cause and cause specific mortality: prospective cohort study. BMJ 10(367):l5584CrossRef Chen C, Ye Y, Zhang Y, Pan XF, Pan A (2019) Weight change across adulthood in relation to all cause and cause specific mortality: prospective cohort study. BMJ 10(367):l5584CrossRef
23.
Zurück zum Zitat Lunt D, Briffa T, Briffa NK, Ramsay J (2003) Physical activity levels of adolescents with congenital heart disease. Aust J Physiother 49(1):43–50PubMedCrossRef Lunt D, Briffa T, Briffa NK, Ramsay J (2003) Physical activity levels of adolescents with congenital heart disease. Aust J Physiother 49(1):43–50PubMedCrossRef
Metadaten
Titel
Sizing Up Fontan Failure: Association with Increasing Weight in Adulthood
verfasst von
Ryan D. Byrne
Angela J. Weingarten
Daniel E. Clark
Steven J. Healan
Tadarro L. Richardson
Shi Huang
Jonathan N. Menachem
Benjamin P. Frischhertz
Publikationsdatum
04.05.2021
Verlag
Springer US
Erschienen in
Pediatric Cardiology / Ausgabe 6/2021
Print ISSN: 0172-0643
Elektronische ISSN: 1432-1971
DOI
https://doi.org/10.1007/s00246-021-02628-8

Weitere Artikel der Ausgabe 6/2021

Pediatric Cardiology 6/2021 Zur Ausgabe

Screening-Mammografie offenbart erhöhtes Herz-Kreislauf-Risiko

26.04.2024 Mammografie Nachrichten

Routinemäßige Mammografien helfen, Brustkrebs frühzeitig zu erkennen. Anhand der Röntgenuntersuchung lassen sich aber auch kardiovaskuläre Risikopatientinnen identifizieren. Als zuverlässiger Anhaltspunkt gilt die Verkalkung der Brustarterien.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Adipositas-Medikament auch gegen Schlafapnoe wirksam

24.04.2024 Adipositas Nachrichten

Der als Antidiabetikum sowie zum Gewichtsmanagement zugelassene Wirkstoff Tirzepatid hat in Studien bei adipösen Patienten auch schlafbezogene Atmungsstörungen deutlich reduziert, informiert der Hersteller in einer Vorab-Meldung zum Studienausgang.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.